229 related articles for article (PubMed ID: 36162737)
1. AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice.
Khandelwal M; Manglani K; Upadhyay P; Azad M; Gupta S
Neurobiol Dis; 2022 Nov; 174():105876. PubMed ID: 36162737
[TBL] [Abstract][Full Text] [Related]
2. AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway.
Liu B; Liu J; Wang JG; Liu CL; Yan HJ
Exp Neurol; 2020 May; 327():113249. PubMed ID: 32070713
[TBL] [Abstract][Full Text] [Related]
3. Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.
Ng RC; Cheng OY; Jian M; Kwan JS; Ho PW; Cheng KK; Yeung PK; Zhou LL; Hoo RL; Chung SK; Xu A; Lam KS; Chan KH
Mol Neurodegener; 2016 Nov; 11(1):71. PubMed ID: 27884163
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer's disease.
Ali T; Rehman SU; Khan A; Badshah H; Abid NB; Kim MW; Jo MH; Chung SS; Lee HG; Rutten BPF; Kim MO
Mol Neurodegener; 2021 Apr; 16(1):23. PubMed ID: 33849621
[TBL] [Abstract][Full Text] [Related]
5. Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer's disease mouse model.
Ng RC; Jian M; Ma OK; Bunting M; Kwan JS; Zhou GJ; Senthilkumar K; Iyaswamy A; Chan PK; Li M; Leung KM; Kumar Durairajan SS; Lam KS; Chu LW; Festenstein R; Chung SK; Chan KH
Mol Psychiatry; 2021 Oct; 26(10):5669-5689. PubMed ID: 32132650
[TBL] [Abstract][Full Text] [Related]
6. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
[TBL] [Abstract][Full Text] [Related]
7. AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer's disease.
Wang C; Chang Y; Zhu J; Wu Y; Jiang X; Zheng S; Li G; Ma R
Exp Neurol; 2023 May; 363():114355. PubMed ID: 36868546
[TBL] [Abstract][Full Text] [Related]
8. The mitochondria-targeted small molecule SS31 delays progression of behavioral deficits by attenuating β-amyloid plaque formation and mitochondrial/synaptic deterioration in APP/PS1 mice.
Jia YL; Wang W; Han N; Sun HL; Dong FM; Song YX; Feng RF; Wang JH
Biochem Biophys Res Commun; 2023 May; 658():36-43. PubMed ID: 37018887
[TBL] [Abstract][Full Text] [Related]
9. Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.
Ahmed S; Jing Y; Mockett BG; Zhang H; Abraham WC; Liu P
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806318
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
11. AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.
Fairaq A; Shawky NM; Osman I; Pichavaram P; Segar L
Pharmacol Res; 2017 May; 119():289-302. PubMed ID: 28237515
[TBL] [Abstract][Full Text] [Related]
12. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
[TBL] [Abstract][Full Text] [Related]
13. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
Lecordier S; Pons V; Rivest S; ElAli A
Front Immunol; 2021; 12():813536. PubMed ID: 35173711
[TBL] [Abstract][Full Text] [Related]
14. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y
BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688
[TBL] [Abstract][Full Text] [Related]
15. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
[TBL] [Abstract][Full Text] [Related]
16. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
[TBL] [Abstract][Full Text] [Related]
17. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
Yuan C; Guo X; Zhou Q; Du F; Jiang W; Zhou X; Liu P; Chi T; Ji X; Gao J; Chen C; Lang H; Xu J; Liu D; Yang Y; Qiu S; Tang X; Chen G; Zou L
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):161-180. PubMed ID: 30389579
[TBL] [Abstract][Full Text] [Related]
18. The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to β-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment.
Ostapchenko VG; Chen M; Guzman MS; Xie YF; Lavine N; Fan J; Beraldo FH; Martyn AC; Belrose JC; Mori Y; MacDonald JF; Prado VF; Prado MA; Jackson MF
J Neurosci; 2015 Nov; 35(45):15157-69. PubMed ID: 26558786
[TBL] [Abstract][Full Text] [Related]
19. Patchouli alcohol as a selective estrogen receptor β agonist ameliorates AD-like pathology of APP/PS1 model mice.
Yan QY; Lv JL; Shen XY; Ou-Yang XN; Yang JZ; Nie RF; Lu J; Huang YJ; Wang JY; Shen X
Acta Pharmacol Sin; 2022 Sep; 43(9):2226-2241. PubMed ID: 35091686
[TBL] [Abstract][Full Text] [Related]
20. 27-hydroxycholesterol promotes Aβ accumulation via altering Aβ metabolism in mild cognitive impairment patients and APP/PS1 mice.
Zhang X; Xi Y; Yu H; An Y; Wang Y; Tao L; Wang Y; Liu W; Wang T; Xiao R
Brain Pathol; 2019 Jul; 29(4):558-573. PubMed ID: 30582229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
